Oncternal Therapeutics, Inc. (ONCT) Financial Ratios Quarterly - Discounting Cash Flows
ONCT
Oncternal Therapeutics, Inc.
ONCT (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
2012 (Q2)
06-30
2012 (Q1)
03-31
2011 (Q4)
12-31
2011 (Q3)
09-30
2011 (Q2)
06-30
2011 (Q1)
03-31
2010 (Q4)
12-31
2010 (Q3)
09-30
2010 (Q2)
06-30
2010 (Q1)
03-31
2009 (Q4)
12-31
2009 (Q3)
09-30
2009 (Q2)
06-30
2009 (Q1)
03-31
2008 (Q4)
12-31
2008 (Q3)
09-30
2008 (Q2)
06-30
2008 (Q1)
03-31
2007 (Q4)
12-31
2007 (Q3)
09-30
2007 (Q2)
06-30
2007 (Q1)
03-31
2006 (Q4)
12-31
2006 (Q3)
09-30
2006 (Q2)
06-30
2006 (Q1)
03-31
2005 (Q4)
12-31
2005 (Q3)
09-30
2005 (Q2)
06-30
2005 (Q1)
03-31
2004 (Q4)
12-31
2004 (Q3)
09-30
2004 (Q2)
06-30
2004 (Q1)
03-31
2003 (Q4)
12-31
2003 (Q3)
09-30
2003 (Q2)
06-30
2003 (Q1)
03-31
Price Ratios
Price to Earnings Ratio -0.039 0 -0.576 -0.754 -1.13 -0.586 -0.925
1234
Price to Sales Ratio 1.99 0 11.24 23.85 54.26 38.15 58.21
1234
Price to Book Ratio 0.052 0.427 1.32 1.2 1.05 -0.094 -0.115
1234
Price to Free Cash Flow Ratio -0.048 0 -0.823 -0.957 -0.979 -0.502 -0.646
1234
Price to Operating Cash Flow Ratio -0.048 0 -0.823 -0.957 -0.979 -0.502 -0.646
1234
Price Earnings to Growth Ratio -0.01 0.111 -0.286 0.091 0.12 -0.046 0.026
1234
EV to EBITDA 4.32 1.66 0.04 -0.039
1234
Liquidity Ratios
Current Ratio 6.94 2.39 2.89 4.66 6.94 8.25 10.37
1234
Quick Ratio 6.94 2.39 2.89 4.66 6.94 8.28 10.37
1234
Cash Ratio 1.29 2.03 0.792 1.05 1.29 2.9 3.28
1234
Debt Ratio 0.009 0.012 0.01 0.01 0.009 0.008 0.007
1234
Debt to Equity Ratio 0.011 0.021 0.015 0.012 0.011 -0.002 -0.002
1234
Long Term Debt to Capitalization 0 0 0 0 0 0 0
1234
Total Debt to Capitalization 0.01 0.02 0.015 0.012 0.01 -0.002 -0.002
1234
Interest Coverage Ratio 0 0 0 0 0 0 0
1234
Cash Flow to Debt Ratio -101.1 -36.4 -24.77 -26.76 -20.19 -16.12 -25.31
1234
Margins
Gross Profit Margin -3,690% 0% -636.7% -964.9% -2,146% 58.1% 65.09%
1234
Operating Profit Margin -5,314% 0% -1,106% -1,543% -3,244% -5,804% -9,005%
1234
Pretax Profit Margin -5,029% 0% -1,069% -1,474% -3,086% -5,509% -8,458%
1234
Net Profit Margin -5,029% 0% -1,069% -1,474% -3,086% -5,509% -8,458%
1234
Operating Cash Flow Margin -4,097% 0% -726.8% -1,307% -2,161% -3,080% -8,739%
1234
Free Cash Flow Margin -4,097% 0% -726.8% -1,307% -2,161% -3,080% -8,739%
1234
Return
Return on Assets -107.5% 0% -151.1% -125.3% -76.31% -69.94% -43.76%
1234
Return on Equity 61.57% 0% -228.8% -159.3% -93.26% 16.02% 12.43%
1234
Return on Capital Employed -132.3% 0% -238.9% -167.2% -93.9% -85.15% -52.19%
1234
Return on Invested Capital 42.11% 0% 694% 1,007% 762.1% 14.17% 10.71%
1234
Turnover Ratios
Receivables Turnover Ratio 1.24 0 1.42 0.794 0.47 0 0
1234
Payables Turnover Ratio 25.92 0 3.1 4.14 5.81 0.035 0.017
1234
Inventory Turnover Ratio 0 0 0 0 0 -0.403 0
1234
Fixed Asset Turnover Ratio 3.04 0 4.22 2.53 1.15 0.615 0.29
1234
Asset Turnover Ratio 0.021 0 0.034 0.02 0.008 0.004 0.002
1234
Per Share Items ()
Revenue Per Share 0.267 0 0.271 0.192 0.101 0.061 0.036
1234
Operating Cash Flow Per Share -10.94 -2.35 -1.97 -2.51 -2.18 -1.87 -3.15
1234
Free Cash Flow Per Share -10.94 -2.35 -1.97 -2.51 -2.18 -1.87 -3.15
1234
Cash & Short Term Investments 11.65 4.92 7.24 9.13 11.62 13.67 15.5
1234
Earnings Per Share -13.43 0 -2.89 -2.83 -3.11 -3.35 -3.05
1234
EBITDA Per Share -2.93 -2.93 0 0 0 -3.5 -3.24
1234
Dividend Per Share 0 0 0 0 0 0 0
1234
Enterprise Value Per Share -12.67 -4.86 -0.14 0.26 -0.792 -7.56 -8.37
1234
Book Value Per Share -21.81 0 5.32 7.75 10.19 -63.98 -60.88
1234
Price Per Share -1.12 0 7.02 9.3 10.72 6 7
1234
Effective Tax Rate 0% 0% 0% 0% 0% 0% 0%
1234
Short Term Coverage Ratio 0 0 0 0 0 -36.51 -63.88
1234
Capital Expenditure Coverage Ratio 0 0 0 0 0 0 0
1234
EBIT Per Revenue -53.14 0 -11.06 -15.43 -32.44 -58.04 -90.05
1234
EBITDA Per Revenue -5.21 None 0 0 0 -57.63 -89.7
1234
Days of Sales Outstanding 293.9 0 63.26 113.4 191.5 0 0
1234
Days of Inventory Outstanding 0 0 0 0 0 -223.2 0
1234
Days of Payables Outstanding 14.08 0 29.02 21.72 15.49 2,560 5,410
1234
Cash Conversion Cycle 279.8 0 34.23 91.69 176 -2,783 -5,410
1234
Cash Conversion Ratio 0.815 0 0.68 0.887 0.7 0.559 1.03
1234
Free Cash Flow to Earnings 0.815 0 0.68 0.887 0.7 0.559 1.03
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program